Impact of COVID-19 Outbreak on Cancer Patient Care and Treatment: Data from an Outpatient Oncology Clinic in Lombardy (Italy).

SARS-CoV-2 cancer containment measures lockdown systemic treatment

Journal

Cancers
ISSN: 2072-6694
Titre abrégé: Cancers (Basel)
Pays: Switzerland
ID NLM: 101526829

Informations de publication

Date de publication:
12 Oct 2020
Historique:
received: 10 08 2020
revised: 07 10 2020
accepted: 07 10 2020
entrez: 15 10 2020
pubmed: 16 10 2020
medline: 16 10 2020
Statut: epublish

Résumé

Lombardy was the first area in Italy to have an outbreak of coronavirus disease 19 (COVID-19) at the beginning of 2020. In this context, cancer has been reported as a major risk factor for adverse outcomes and death, so oncology societies have quickly released guidelines on cancer care during the pandemic. The aim of this study was to investigate the management of cancer patients and oncological treatments during the COVID-19 pandemic and to describe the containment measures performed in our outpatient clinic at Pavia (Lombardy). A comparison with the same period of the four previous years (2019, 2018, 2017, and 2016) was also performed. Using our electronic databases, we evaluated the number and characteristics of patients accessing the hospital for anticancer drug infusion from 24 February, 2020 to 30 April, 2020 and the number of radiological exams performed. Although a significant reduction in access for therapy was seen when compared with 2019 (2590 versus 2974, access rate ratio (ARR) = 0.85,

Identifiants

pubmed: 33053782
pii: cancers12102941
doi: 10.3390/cancers12102941
pmc: PMC7601200
pii:
doi:

Types de publication

Journal Article

Langues

eng

Références

Cancers (Basel). 2020 May 19;12(5):
pubmed: 32438703
Cancers (Basel). 2020 Jun 10;12(6):
pubmed: 32531948
Eur J Cancer. 2020 Jun;132:199-206
pubmed: 32380430
Psychooncology. 2015 Nov;24(11):1521-8
pubmed: 25914244
JAMA. 2020 May 12;323(18):1775-1776
pubmed: 32203977
Breast. 2020 Aug;52:8-16
pubmed: 32334323
Ann Oncol. 2020 Aug;31(8):1084-1085
pubmed: 32330540
Tumori. 2020 May 4;:300891620923790
pubmed: 32364028
JCO Oncol Pract. 2020 Jun;16(6):295-298
pubmed: 32364846
Nat Rev Clin Oncol. 2020 Jul;17(7):386-388
pubmed: 32424196
ESMO Open. 2020 Mar;5(2):
pubmed: 32229501
Oncologist. 2020 Jun;25(6):463-467
pubmed: 32298029
J Natl Compr Canc Netw. 2020 Mar 20;:1-4
pubmed: 32197238
Oncologist. 2020 Jul;25(7):e1013-e1020
pubmed: 32412693
Cancers (Basel). 2020 Jun 15;12(6):
pubmed: 32549297
Front Oncol. 2020 Apr 22;10:665
pubmed: 32391282
Lancet Oncol. 2020 Jul;21(7):904-913
pubmed: 32479787
Lancet Oncol. 2020 Aug;21(8):1023-1034
pubmed: 32702310
Eur J Cancer. 2020 Jun;132:17-23
pubmed: 32311643
JCO Oncol Pract. 2020 Jun 23;:OP2000297
pubmed: 32574131
Am J Prev Med. 2007 Sep;33(3):222-49
pubmed: 17826584
Ecancermedicalscience. 2020 May 15;14:1046
pubmed: 32565899
BMC Geriatr. 2015 Jul 09;15:79
pubmed: 26156892
Clin Colorectal Cancer. 2020 Sep;19(3):156-164
pubmed: 32513593
Front Oncol. 2020 Apr 23;10:734
pubmed: 32391283

Auteurs

Erica Quaquarini (E)

Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, 27100 Pavia, Italy.
Experimental Medicine School, University of Pavia, 27100 Pavia, Italy.

Giuseppe Saltalamacchia (G)

Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, 27100 Pavia, Italy.

Daniele Presti (D)

Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, 27100 Pavia, Italy.

Giulia Caldana (G)

Translational Oncology Unit, ICS Maugeri-IRCCS SpA SB, 27100 Pavia, Italy.

Valentina Tibollo (V)

Laboratory of Informatics and System Engineering for Clinical Research, ICS Maugeri-IRCCS SpA SB, 27100 Pavia, Italy.

Alberto Malovini (A)

Laboratory of Informatics and System Engineering for Clinical Research, ICS Maugeri-IRCCS SpA SB, 27100 Pavia, Italy.

Raffaella Palumbo (R)

Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, 27100 Pavia, Italy.

Cristina Maria Teragni (CM)

Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, 27100 Pavia, Italy.

Emanuela Balletti (E)

Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, 27100 Pavia, Italy.

Ludovica Mollica (L)

Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, 27100 Pavia, Italy.

Elisa Biscaldi (E)

Translational Oncology Unit, ICS Maugeri-IRCCS SpA SB, 27100 Pavia, Italy.

Mara Frascaroli (M)

Translational Oncology Unit, ICS Maugeri-IRCCS SpA SB, 27100 Pavia, Italy.

Antonio Bernardo (A)

Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, 27100 Pavia, Italy.

Federico Sottotetti (F)

Medical Oncology Unit, ICS Maugeri-IRCCS SpA SB, 27100 Pavia, Italy.

Classifications MeSH